Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Recro Pharma, Inc. (NASDAQ: REPH).

Full DD Report for REPH

You must become a subscriber to view this report.


Recent News from (NASDAQ: REPH)

Recro Pharma to Participate in Upcoming Investor Conferences
MALVERN, Pa., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today announced that Recro Pharma management will participate in the following upc...
Source: GlobeNewswire
Date: September, 10 2018 07:00
Your Daily Scoop: Recro Proceeds, MannKind Zooms, Aduro's Publication
News in focus: REPH, MNKD Recro Pharma plans to resubmit NDA Discussion : On September 4, Recro Pharma ( REPH ) reported positive outcome of its meeting with the FDA regarding its NDA for IV meloxicam that was rejected in last May. Based on the discussion with the FDA, the comp...
Source: SeekingAlpha
Date: September, 07 2018 16:31
Recro Pharma to Present IV Meloxicam Data at PAINWeek® 2018
MALVERN, Pa., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today announced three poster presentations at PAINWeek 2018, taking place Septembe...
Source: GlobeNewswire
Date: September, 05 2018 07:00
Technology - Top 5 Gainers / Losers as of 2.55 PM (09/05/2018)
Gainers: MNKD +75% . EPIX +32% . NCTY +31% . TA +29% . REPH +22% . More news on: MannKind Corporation, ESSA Pharma, Inc., The9 Limited, Tech stocks news, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: September, 04 2018 14:55

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-148.328.508.528.17189,136
2018-05-2111.7812.0112.3011.78300,487
2018-05-1811.0711.7211.8511.02251,146
2018-05-1710.8511.0311.1210.70164,899
2018-05-1610.7510.8711.0210.66233,596

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-0712,82978,13116.4199Cover
2018-12-0624,98783,61729.8827Cover
2018-12-042,07029,1527.1007Cover
2018-12-0326,15972,73235.9663Short
2018-11-305,40236,99414.6024Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on REPH.


About Recro Pharma, Inc. (NASDAQ: REPH)

Logo for Recro Pharma, Inc. (NASDAQ: REPH)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: REPH)

      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: September, 05 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: September, 04 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: August, 07 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: August, 07 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 24 2018
      Amendment to the SC 13G filing
      Filing Type: SC 13G/AFiling Source: edgar
      Filing Date: May, 24 2018
      Securities offered to employees under employee benefit plans
      Filing Type: S-8Filing Source: edgar
      Filing Date: May, 11 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 10 2018
      Amendment to a previously filed Form 4
      Filing Type: 4/AFiling Source: edgar
      Filing Date: May, 10 2018
      Amendment to a previously filed Form 4
      Filing Type: 4/AFiling Source: edgar
      Filing Date: May, 10 2018

       

       


      Daily Technical Chart for (NASDAQ: REPH)

      Daily Technical Chart for (NASDAQ: REPH)


      Stay tuned for daily updates and more on (NASDAQ: REPH)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: REPH)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in REPH is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of REPH and does not buy, sell, or trade any shares of REPH. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/